RxDoctor Payments Data

Benjamin Dorenkamp, DO

Orthopaedic Surgery of the Spine · Lansing, MINPI 1417349986

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (48.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.1%. Reporting peaked in 2021 at $7,950 and has fallen 89.6% since, to $830 in 2025.

$15,269in general payments, 2019–2025

Across 201 payments — averaging $75.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$3K
  • Seaspine Orthopedics Corporation$3K
  • Johnson & Johnson$3K
  • Brainlab, Inc.$2K
  • Boston Scientific$1K
  • Medwest Associates$708
  • plus $3K from 21 others
$18,758in research payments, 2019–2025

Across 13 payments — averaging $1442.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$19K

What the payments were for

  • Travel & lodging$7,17147%
  • Food & beverage$7,32748%
  • Education$7085%
  • Entertainment$630%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,269 in reported general payments places this provider in the 55th percentile of 37 orthopaedic surgery of the spine providers in Michigan.

See all orthopaedic surgery of the spine providers in Michigan

Medicare billing

Part B allowed, 2024
$156,945
Medicare patients
274
Services billed
963

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin112$866
Methocarbamol33$293
Oxycodone Hcl42$259
Celecoxib21$236
Meloxicam47$100
Tramadol Hcl22$58
Cyclobenzaprine Hcl12$31
Diazepam14$14

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →